Study Path Agent Study Path Agent
Generate Your Own
Mitral regurgitation
104 topics across 6 chapters
Chapter 1
Mitral valve & cardiac physiology fundamentals
1
Mitral valve anatomy: leaflets, annulus, chordae, papillary muscles
2 subtopics
2
Identify scallops/segments (A1-A3, P1-P3) and commissures
3
Understand annular dynamics and the role of the saddle shape
4
Cardiac cycle & pressure-volume relationships relevant to MR
2 subtopics
5
Trace the normal sequence of valve opening/closure across systole/diastole
6
Explain why MR can reduce effective forward cardiac output despite preserved EF
7
Hemodynamics of regurgitation: preload/afterload, forward vs regurgitant stroke volume
2 subtopics
8
Differentiate regurgitant volume, regurgitant fraction, and effective regurgitant orifice area (EROA)
9
Predict how afterload reduction changes MR severity (acute vs chronic contexts)
10
Left atrial and left ventricular remodeling in chronic MR
2 subtopics
11
Describe LA dilation consequences: AF risk and thromboembolism implications
12
Recognize LV dilation patterns and thresholds used in surgical timing discussions
Chapter 2
Etiology & mechanisms of mitral regurgitation
13
Primary (degenerative) MR: myxomatous disease, MVP, flail leaflet
2 subtopics
14
Mechanism of MVP: leaflet prolapse vs flail; chordal elongation vs rupture
15
Recognize degenerative MR phenotypes: Barlow disease vs fibroelastic deficiency
16
Secondary (functional) MR: ischemic and non-ischemic LV remodeling
2 subtopics
17
Tethering and annular dilation: concept of leaflet coaptation depth and tenting area
18
Ischemic MR: papillary muscle displacement patterns after MI
19
Acute MR mechanisms: papillary muscle rupture, chordal rupture, endocarditis
3 subtopics
20
Post-MI papillary muscle rupture: presentation, exam, and emergency pathway
21
Chordae tendineae rupture: triggers (trauma, degenerative) and echo clues
22
Endocarditis-related MR: perforation, vegetation, abscess, and embolic risk
23
Carpentier classification & valve dysfunction language (Type I/II/III)
2 subtopics
24
Map Carpentier types to typical causes (e.g., Type II → prolapse/flail)
25
Use mechanism language to communicate with surgeons/interventionalists (repair planning)
Chapter 3
Clinical presentation & bedside assessment
26
Symptoms & natural history: asymptomatic phase to heart failure
2 subtopics
27
Differentiate acute vs chronic MR symptom patterns and compensation
28
Recognize progression triggers: AF onset, LV dysfunction, pulmonary hypertension
29
Cardiac auscultation: MR murmurs and key maneuver effects
3 subtopics
30
Identify holosystolic murmur at apex with axillary radiation and correlate to MR
31
Explain how handgrip/squatting typically increases MR murmur intensity
32
Distinguish MR murmur features from MVP (mid-systolic click ± late systolic murmur)
33
Physical exam & complications: pulmonary edema, AF, pulmonary hypertension
3 subtopics
34
Recognize signs of left-sided congestion: orthopnea, rales, pleural effusions
35
Atrial fibrillation in MR: rate vs rhythm strategy basics and anticoagulation triggers
36
Pulmonary hypertension and RV dysfunction: why it matters for prognosis and surgery
37
Differential diagnosis of a systolic murmur (MR vs TR vs AS vs VSD)
2 subtopics
38
Differentiate MR vs TR using location, radiation, and respiration effects
39
Differentiate MR from AS and VSD using timing, quality, and associated findings
Chapter 4
Diagnostics: echo-first workflow & severity assessment
40
Transthoracic echocardiography (TTE): core views & MR screening
2 subtopics
41
Perform a structured TTE MR read: mechanism, jet direction, chamber sizes, LV function
42
Recognize common pitfalls: eccentric jets, Coanda effect, loading conditions
43
MR severity quantification on echo: qualitative, semiquantitative, quantitative
4 subtopics
44
Qualitative signs: color jet characteristics, pulmonary vein flow, CW Doppler density
45
Semiquantitative metrics: vena contracta width and its limitations
46
Quantitative methods: PISA/EROA calculation steps and common error sources
47
Integrate parameters into a final severity grade (avoid single-metric diagnosis)
48
Transesophageal echo (TEE) & 3D echo for mechanism and repair planning
2 subtopics
49
TEE indications: nondiagnostic TTE, endocarditis suspicion, pre-procedural planning
50
3D echo: commissural view orientation and segment localization for repair/TEER
51
Stress testing & exercise echo for asymptomatic MR and symptoms mismatch
2 subtopics
52
Exercise testing endpoints: symptoms, BP response, arrhythmias, functional capacity
53
Exercise echo: uncovering dynamic MR and pulmonary pressure rise
54
Adjunct testing: ECG, CXR, biomarkers, CMR, and cardiac cath when indicated
5 subtopics
55
ECG patterns: AF, LVH, prior MI clues; when ambulatory monitoring helps
56
Chest X-ray: LA enlargement, pulmonary venous congestion, edema
57
Biomarkers: BNP/NT-proBNP for prognosis and symptom interpretation (limitations)
58
Cardiac MRI (CMR) in MR: LV volumes, regurgitant fraction, fibrosis assessment
59
Cardiac cath: coronary evaluation pre-op and hemodynamics when echo is discordant
Chapter 5
Management: medical therapy, follow-up, and timing of intervention
60
Risk stratification & surveillance: stages, echo follow-up intervals, red flags
3 subtopics
61
Stage MR (A-D) and relate stage to management decisions
62
Plan surveillance echo frequency based on severity and LV size/function
63
Red flags requiring urgent referral: acute symptoms, new AF, LV EF drop, PH
64
Medical management for chronic MR: HF therapy, BP control, AF management principles
3 subtopics
65
Use diuretics and BP control to manage congestion and reduce symptoms (when appropriate)
66
Guideline-directed medical therapy (GDMT) principles in secondary MR with HFrEF
Atrial fibrillation in MR: rate vs rhythm strategy basics and anticoagulation triggers (see Chapter 3)
67
Acute severe MR stabilization: oxygenation, afterload reduction, MCS, urgent consults
3 subtopics
68
Immediate stabilization priorities: airway/oxygenation and pulmonary edema treatment
69
Afterload reduction and inotropes: when to consider (conceptual, not dosing)
70
Mechanical circulatory support concepts (IABP/Impella/ECMO) and escalation triggers
71
Indications for mitral valve repair vs replacement (primary MR focus)
3 subtopics
72
Repair vs replace: advantages, contraindications, and expected outcomes
73
Timing in asymptomatic severe primary MR: LV EF/LV size, AF, pulmonary pressures
74
Role of high-volume valve centers and repair probability in decision-making
75
Functional (secondary) MR treatment pathway: GDMT, CRT, revascularization, TEER selection
4 subtopics
76
Optimize HF medications and volume status before considering interventions
77
Cardiac resynchronization therapy (CRT): which patients may improve MR
78
Revascularization in ischemic MR: CABG/PCI concepts and patient selection
79
TEER candidacy basics: anatomy, symptom status, optimized GDMT requirement
Chapter 6
Procedural options & special populations
80
Surgical mitral valve repair: common techniques & durability considerations
3 subtopics
81
Annuloplasty ring/band: purpose, sizing concepts, and impact on MR recurrence
82
Leaflet repair options: triangular/quadrangular resection, neochords
83
Post-repair assessment: residual MR, transmitral gradient, SAM risk
84
Surgical mitral valve replacement: prosthesis choices & anticoagulation basics
3 subtopics
85
Mechanical vs bioprosthetic valves: durability vs anticoagulation trade-offs
86
Anticoagulation basics after MVR: INR monitoring concepts and drug interactions
87
Valve complications: thrombosis, pannus, structural valve degeneration, endocarditis
88
Transcatheter edge-to-edge repair (TEER) and other transcatheter options
3 subtopics
TEER candidacy basics: anatomy, symptom status, optimized GDMT requirement (see Chapter 5)
89
TEER procedure overview: transseptal access, clip positioning, residual gradient concerns
90
Post-TEER follow-up: echo parameters, antithrombotic strategy concepts, complications
91
MR in pregnancy, perioperative non-cardiac surgery, and athletics
3 subtopics
92
Pregnancy and MR: hemodynamic changes, risk assessment, delivery planning concepts
93
Non-cardiac surgery with MR: pre-op evaluation and intra-op hemodynamic goals
94
Sports participation: when MR is compatible with competitive athletics (conceptual)
95
Endocarditis, rheumatic disease, and valve-related complications
3 subtopics
Endocarditis-related MR: perforation, vegetation, abscess, and embolic risk (see Chapter 2)
96
Rheumatic mitral disease: mixed MS/MR patterns and long-term considerations
97
Infective endocarditis prophylaxis: who qualifies and dental procedure basics